645 filings
Page 3 of 33
8-K
feoz76 wqucg0
31 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
UPLOAD
lcu7pyfb 0j
23 Mar 23
Letter from SEC
12:00am
8-K
7fx8ylm4e4t1gvn
15 Mar 23
Vaxart Provides Business Update and Full Year 2022 Financial Results
7:58pm
8-K
niopp4rol3h 4pzaks
19 Dec 22
Vaxart Names Phillip Lee as Chief Financial Officer
5:25pm
8-K
30imyr
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm
8-K
9yabquj yi6
8 Nov 22
Vaxart Provides Business Update and Reports Third Quarter 2022 Financial Results
4:10pm
S-8
lc1ollz
21 Oct 22
Registration of securities for employees
9:04pm
8-K
mzskh80 q8ft
1 Sep 22
Regulation FD Disclosure
7:05am
8-K
wmwqdta3 4b6hkxyihu
25 Aug 22
Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
4:09pm
8-K
95jd8
8 Aug 22
Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results
4:06pm
8-K/A
ix30hrthg
5 Aug 22
Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4
8:02am
8-K
20ei6kc 2rfsqkxoih6t
28 Jul 22
Other Events
8:00am
DEFA14A
64mhjsvoic9hl3r4dq1
26 Jul 22
Additional proxy soliciting materials
3:35pm
DEFA14A
ptta34lau bm
26 Jul 22
Additional proxy soliciting materials
11:11am
DEFA14A
0dwq4zj2t1s
12 Jul 22
Additional proxy soliciting materials
4:03pm